GLP-1 mediations like semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound) are FDA-approved prescription medications that have shown powerful results for people with obesity and type 2 diabetes
10-19, 2025, with 4,489 total U.S
Provider Review: A licensed medical provider reviews your information to ensure safety and eligibility
Semaglutide, liraglutide, and tirzepatide are no longer on the shortage list, but some companies have continued to provide the drugs to patients under exceptions for 'personalised' treatments under a framework known as Section 503A, which allows compounders to make compounds in small quantities for patients whose needs - they claim - are not met by a standard formulation
This peptide blend enables researchers to examine complementary receptor pharmacology mechanisms within controlled laboratory environments, providing insights into complex signalling cascade interactions across multiple cell model systems
We just got trademarked